Immunotherapy on Neurodegenarative Diseases: Mini Review

Authors

  • Kishor Danao Dadasaheb Balpande College of Pharmacy, Besa, Nagpur (MS) 440037
  • Kailash Jatwe Department of Pharmaceutical Chemistry, Dadasaheb Balpande College of Pharmacy, Besa, Nagpur
  • Ujwala Mahajan Department of Pharmaceutical Chemistry, Dadasaheb Balpande College of Pharmacy, Besa, Nagpur

DOI:

https://doi.org/10.7439/ijpr.v9i11.5340

Keywords:

Alzheimer's disease, pathophysiology, Immunotherapy

Abstract

Neurodegenerative disease is a range of conditions which primarily affect the neurons in the human brain. Neurons are the building blocks of the nervous system which includes the brain and spinal cord. Neurodegenerative diseases are incurable and debilitating conditions that result in progressive degeneration and / or death of nerve cells. This causes problems with movement (called ataxias), or mental functioning (called dementias). Neurodegenerative diseases (NDs) have a serious impact on global health with no effective treatments available to date. Vaccination has been proposed as a therapeutic approach for NDs, and clinical evaluations of some candidates for Alzheimer's disease and multiple sclerosis are ongoing. Moreover, monoclonal antibodies for passive immunotherapy are under evaluation for Common Neurodegenarative diseases such as Alzheimer

Downloads

Download data is not yet available.

Downloads

Published

2019-11-30

Issue

Vol. 9 No. 11 (2019): Nov

Section

Review Article

License

Authors who publish with this journal agree to the following terms:

    1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
    2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
    3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
    4. Author must Submit Copyright form  After acceptance of Article

How to Cite

1.
Danao K, Jatwe K, Mahajan U. Immunotherapy on Neurodegenarative Diseases: Mini Review. Int J of Pharmc Res [Internet]. 2019 Nov. 30 [cited 2025 Mar. 14];9(11):e5340. Available from: https://ssjournals.co.in/index.php/ijpr/article/view/5340
Crossref
Scopus
Google Scholar
Europe PMC